Search Results

There are 8918 results for: content related to: Effect of adalimumab on clinical laboratory parameters in patients with Crohn's disease: Results from the CHARM trial

  1. You have free access to this content
    Adalimumab sustains clinical remission and overall clinical benefit after 2 years of therapy for Crohn’s disease

    Alimentary Pharmacology & Therapeutics

    Volume 31, Issue 12, June 2010, Pages: 1296–1309, R. PANACCIONE, J.-F. COLOMBEL, W. J. SANDBORN, P. RUTGEERTS, G. R. D’HAENS, A. M. ROBINSON, J. CHAO, P. M. MULANI and P. F. POLLACK

    Version of Record online : 18 MAR 2010, DOI: 10.1111/j.1365-2036.2010.04304.x

  2. You have free access to this content
    2015 ACR/ARHP Annual Meeting Abstract Supplement

    Arthritis & Rheumatology

    Volume 67, Issue S10, October 2015, Pages: 1–4046,

    Version of Record online : 5 NOV 2015, DOI: 10.1002/art.39448

  3. Risk–benefit analysis of adalimumab versus traditional non-biologic therapies for patients with Crohn's disease

    Inflammatory Bowel Diseases

    Volume 17, Issue 1, January 2011, Pages: 127–140, Edward V. Loftus Jr, Scott J. Johnson, Si-Tien Wang, Eric Wu, Parvez M. Mulani and Jingdong Chao

    Version of Record online : 1 JUN 2010, DOI: 10.1002/ibd.21341

  4. You have free access to this content
    Adalimumab in Japanese patients with moderate to severe chronic plaque psoriasis: Efficacy and safety results from a Phase II/III randomized controlled study

    The Journal of Dermatology

    Volume 37, Issue 4, April 2010, Pages: 299–310, Akihiko ASAHINA, Hidemi NAKAGAWA, Takafumi ETOH, Mamitaro OHTSUKI and THE ADALIMUMAB M04-688 STUDY GROUP

    Version of Record online : 26 FEB 2010, DOI: 10.1111/j.1346-8138.2009.00748.x

  5. You have free access to this content
    ACR Meeting

    Arthritis & Rheumatism

    Volume 64, Issue S10, October 2012, Pages: S1–S1216,

    Version of Record online : 11 OCT 2012, DOI: 10.1002/art.37735

  6. Efficacy, safety and medication cost implications of adalimumab 40 mg weekly dosing in patients with psoriasis with suboptimal response to 40 mg every other week dosing: results from an open-label study

    British Journal of Dermatology

    Volume 167, Issue 3, September 2012, Pages: 658–667, C. Leonardi, J.M. Sobell, J.J. Crowley, U. Mrowietz, Y. Bao, P.M. Mulani, Y. Gu and M.M. Okun

    Version of Record online : 20 AUG 2012, DOI: 10.1111/j.1365-2133.2012.11041.x

  7. You have full text access to this OnlineOpen article
    Adalimumab maintains remission of Crohn's disease after up to 4 years of treatment: data from CHARM and ADHERE

    Alimentary Pharmacology & Therapeutics

    Volume 38, Issue 10, November 2013, Pages: 1236–1247, R. Panaccione, J.-F. Colombel, W. J. Sandborn, G. D'Haens, Q. Zhou, P. F. Pollack, R. B. Thakkar and A. M. Robinson

    Version of Record online : 22 SEP 2013, DOI: 10.1111/apt.12499

  8. Adalimumab for treating rheumatoid arthritis

    Intervention Review

    The Cochrane Library

    Federico Navarro-Sarabia, Rafael Ariza-Ariza, Blanca Hernandez-Cruz and Isidro Villanueva

    Published Online : 20 JUL 2005, DOI: 10.1002/14651858.CD005113.pub2

  9. You have free access to this content
    Adalimumab treatment optimization for psoriasis: Results of a long-term phase 2/3 Japanese study

    The Journal of Dermatology

    Volume 42, Issue 11, November 2015, Pages: 1042–1052, Akihiko Asahina, Mamitaro Ohtsuki, Takafumi Etoh, Yihua Gu, Martin M. Okun, Henrique D. Teixeira, Yuji Yamaguchi and Hidemi Nakagawa

    Version of Record online : 29 JUN 2015, DOI: 10.1111/1346-8138.13001

  10. Dosage adjustment during long-term adalimumab treatment for Crohn's disease: Clinical efficacy and pharmacoeconomics

    Inflammatory Bowel Diseases

    Volume 17, Issue 1, January 2011, Pages: 141–151, William J. Sandborn, Jean-Frédéric Colombel, Stefan Schreiber, Scott E. Plevy, Paul F. Pollack, Anne M. Robinson, Jingdong Chao and Parvez Mulani

    Version of Record online : 10 MAY 2010, DOI: 10.1002/ibd.21328

  11. The effectiveness and safety of adalimumab in the treatment of non-reimbursed patients with mild-to-moderate psoriasis

    Journal of the European Academy of Dermatology and Venereology

    Volume 26, Issue 8, August 2012, Pages: 991–998, H.-Y. Chiu, T.-S. Wang, C.-Y. Chang and T.-F. Tsai

    Version of Record online : 4 AUG 2011, DOI: 10.1111/j.1468-3083.2011.04199.x

  12. Abstracts from the 2008 Advances in Inflammatory Bowel Diseases, Crohn's & Colitis Foundation's National Clinical & Research Conference

    Inflammatory Bowel Diseases

    Volume 14, Issue S3, December 2008, Pages: S1–S49,

    Version of Record online : 26 NOV 2008, DOI: 10.1002/ibd.20829

  13. Adalimumab (Humira)

    Handbook of Therapeutic Antibodies

    Hartmut Kupper, Jochen Salfeld, Daniel Tracey, Joachim R. Kalden, Pages: 696–732, 2008

    Published Online : 1 FEB 2008, DOI: 10.1002/9783527619740.ch27

  14. You have free access to this content
    Comparison of long-term clinical outcome with etanercept treatment and adalimumab treatment of rheumatoid arthritis with respect to immunogenicity

    Arthritis & Rheumatism

    Volume 64, Issue 12, December 2012, Pages: 3850–3855, Charlotte L. Krieckaert, Anna Jamnitski, Michael T. Nurmohamed, Piet J. Kostense, Maarten Boers and Gertjan Wolbink

    Version of Record online : 28 NOV 2012, DOI: 10.1002/art.34680

  15. Etanercept for patients with psoriasis who did not respond or who lost their response to adalimumab or infliximab

    Journal of the European Academy of Dermatology and Venereology

    Volume 29, Issue 8, August 2015, Pages: 1576–1581, R. Bissonnette, C. Maari, K. Barber, C.W. Lynde and R. Vender

    Version of Record online : 20 JAN 2015, DOI: 10.1111/jdv.12943

  16. You have free access to this content
    Adalimumab, a fully human anti–tumor necrosis factor α monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: The ARMADA trial

    Arthritis & Rheumatism

    Volume 48, Issue 1, January 2003, Pages: 35–45, Michael E. Weinblatt, Edward C. Keystone, Daniel E. Furst, Larry W. Moreland, Michael H. Weisman, Charles A. Birbara, Leah A. Teoh, Steven A. Fischkoff and Elliot K. Chartash

    Version of Record online : 10 JAN 2003, DOI: 10.1002/art.10697

  17. Adalimumab for Crohn's disease in clinical practice at Mayo clinic: The first 118 patients

    Inflammatory Bowel Diseases

    Volume 16, Issue 11, November 2010, Pages: 1912–1921, Jason M. Swoger, Edward V. Loftus Jr., William J. Tremaine, William A. Faubion, Darrell S. Pardi, Sunanda V. Kane, Karen A. Hanson, W. Scott Harmsen, Alan R. Zinsmeister and William J. Sandborn

    Version of Record online : 1 APR 2010, DOI: 10.1002/ibd.21272

  18. Interventions for hidradenitis suppurativa

    Intervention Review

    The Cochrane Library

    John R Ingram, Pick-Ngor Woo, Ser Ling Chua, Anthony D Ormerod, Nemesha Desai, Anneke C Kai, Kerry Hood, Tara Burton, Francisco Kerdel, Sarah E Garner and Vincent Piguet

    Published Online : 7 OCT 2015, DOI: 10.1002/14651858.CD010081.pub2

  19. You have free access to this content
    TNF-alpha inhibitors for ankylosing spondylitis

    Intervention Review

    The Cochrane Library

    Lara J Maxwell, Jane Zochling, Annelies Boonen, Jasvinder A Singh, Mirella MS Veras, Elizabeth Tanjong Ghogomu, Maria Benkhalti Jandu, Peter Tugwell and George A Wells

    Published Online : 18 APR 2015, DOI: 10.1002/14651858.CD005468.pub2

  20. Sequential use of biologics in the treatment of moderate-to-severe plaque psoriasis

    British Journal of Dermatology

    Volume 167, Issue s3, November 2012, Pages: 12–20, J. Leman and A.D. Burden

    Version of Record online : 22 OCT 2012, DOI: 10.1111/j.1365-2133.2012.11209.x